feed,title,long_url,short_url
Benzinga,Eli Lilly's JAK Inhibitor Baricitinib Cuts Death Risk By 13% In COVID-19 Patients,https://benzinga.com/general/biotech/22/03/25970443/eli-lillys-jak-inhibitor-baricitinib-cuts-death-risk-by-13-in-covid-19-patients,https://bit.ly/349i3Pk
